Elevated GBP1 expression has also been shown to be associated with chemotherapy resistance in lung, breast, and ovarian cancer (Duan et al., 2006; Fekete and Győrffy, 2019; Cheng et al., 2020). This evidence concerns the gene GBP1 and ovarian carcinoma.